Author | Anastasios Raptis, MD | OncLive

Author | Anastasios Raptis, MD


Dr. Raptis on DRd in Newly Diagnosed Multiple Myeloma

July 10, 2019


Anastasios Raptis, MD, a clinical assistant professor of medicine at the University of Pittsburgh School of Medicine Hillman Cancer Center, discusses the use of daratumumab (Darzalex), lenalidomide (Revlimid), and dexamethasone (DRd) in the treatment of patients with newly diagnosed multiple myeloma.